Literature DB >> 7718765

Prevalence of the myelodysplastic syndromes in Japan.

H Shimizu1, Y Matsushita, K Aoki, T Nomura, Y Yoshida, H Mizoguchi.   

Abstract

To determine the prevalence of the myelodysplastic syndromes (MDS) in Japan, we conducted a nationwide survey in 1991. The survey included the sex, birth date and type of MDS of the patients from all (n = 2315) hospitals with 200 beds or more and 188 hospitals randomly selected from 7526 hospitals (1/40) with 199 beds or less. The point prevalence of MDS was estimated to be almost 3000 as of September 1, 1991, and it was 3.4 per 100,000 men of 15 years old or older and 2.1 per 100,000 women of 15 years old or older. Refractory anemia (RA) was most common (51%) followed by RA with excess of blasts (RAEB; 18%) and RAEB in transformation (RAEB-t; 14%). RAEB, RAEB-t and chronic myelomonocytic leukemia (CMML) showed a high male/female ratio (3.0 or higher) although the sex ratio of other types was almost 1.0.

Entities:  

Mesh:

Year:  1995        PMID: 7718765     DOI: 10.1016/0925-5710(94)00339-g

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  5 in total

1.  First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America.

Authors:  Achandira M Udayakumar; Nagla Fawaz; Anil Pathare; Shakila Asraf; Mohammed Al-Huneini; Khalil Al-Farsi; Salam Al-Kindi; Murtadha Al-Khabouri
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

Review 2.  Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics.

Authors:  C Aul; A Giagounidis; U Germing
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

3.  Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.

Authors:  Rekha Chaubey; Sudha Sazawal; Rima Dada; Manoranjan Mahapatra; Renu Saxena
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

4.  The incidence of myelodysplastic syndromes in Western Greece is increasing.

Authors:  Christina Avgerinou; Yannis Alamanos; Panagiotis Zikos; Polyxeni Lampropoulou; Maria Melachrinou; Vassiliki Labropoulou; Ioannis Tavernarakis; Anthi Aktypi; Panagiotis Kaiafas; Christos Raptis; Alexandra Kouraklis; Marina Karakantza; Argiris Symeonidis
Journal:  Ann Hematol       Date:  2013-04-10       Impact factor: 3.673

5.  Incidence of myelodysplastic syndrome in Japan.

Authors:  Dai Chihara; Hidemi Ito; Kota Katanoda; Akiko Shibata; Tomohiro Matsuda; Tomotaka Sobue; Keitaro Matsuo
Journal:  J Epidemiol       Date:  2014-08-02       Impact factor: 3.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.